2012年OSAHS相关性高血压诊治共识

2012-03-30 MedSci MedSci原创

     李南方 教授     第二届中国高血压大会暨中国医师协会高血压专业委员会年会于3月16~18日在北京国际会议中心举行,新疆维吾尔自治区人民医院副院长、新疆高血压研究所所长李南方教授介绍了《阻塞性睡眠呼吸暂停相关性高血压临床诊断和治疗专家共识》。该共识由中国医师协会高血压专业委员会、中华医学会呼吸医学分会睡眠呼吸疾病学组联合制定。   许多高血压患者合并有睡眠呼吸暂停低通气综合征(S

     李南方 教授     第二届中国高血压大会暨中国医师协会高血压专业委员会年会于3月16~18日在北京国际会议中心举行,新疆维吾尔自治区人民医院副院长、新疆高血压研究所所长李南方教授介绍了《阻塞性睡眠呼吸暂停相关性高血压临床诊断和治疗专家共识》。该共识由中国医师协会高血压专业委员会、中华医学会呼吸医学分会睡眠呼吸疾病学组联合制定。   许多高血压患者合并有睡眠呼吸暂停低通气综合征(SAS)。SAS可以导致和(或)加重高血压,与高血压的发生发展密切相关,是最为重要继发性高血压,也是冠心病、心律失常、脑卒中等多种疾病的独立危险因素。临床上SAS患者中绝大多数为阻塞性睡眠呼吸暂停低通气综合征(OSAHS)。约50%-92%的OSAHS患者合并有高血压,而30%-50%的高血压患者同时伴有OSAHS。我国OSAHS人群的高血压患病率为56.2%,顽固性高血压与OSAHS关系更为密切,在OSAHS【呼吸暂停低通气指数(AHI)≧10次/小时】患者中的顽固性高血压患病率为83%。与OSAHS相关联的高血压称为阻塞性睡眠呼吸暂停相关性高血压,合理和规范的诊断治疗阻塞性睡眠呼吸暂停相关性高血压

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=37758, encodeId=08673e75876, content=谢谢分享。, beContent=null, objectType=article, channel=null, level=null, likeNumber=193, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200723/f987384a19f54db58fdf3fa313ecf7b2/2405b3e51f384f5d87b2b06c7a0dd7ad.jpg, createdBy=88ac1654221, createdName=笑笑笑子昂, createdTime=Tue Oct 06 20:00:00 CST 2015, time=2015-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1755539, encodeId=46fb1e55539e5, content=<a href='/topic/show?id=1978134916f' target=_blank style='color:#2F92EE;'>#OSAHS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13491, encryptionId=1978134916f, topicName=OSAHS)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8aef36947190, createdName=ylz8415, createdTime=Tue Nov 20 20:18:00 CST 2012, time=2012-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1837086, encodeId=7871183e08659, content=<a href='/topic/show?id=3f34e253206' target=_blank style='color:#2F92EE;'>#相关性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72532, encryptionId=3f34e253206, topicName=相关性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9de34, createdName=shenxlcyp, createdTime=Mon Dec 03 05:18:00 CST 2012, time=2012-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=4159, encodeId=82184159b7, content=keyi, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d64528733, createdName=yourlikes, createdTime=Tue Apr 03 12:14:00 CST 2012, time=2012-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1349724, encodeId=14261349e242f, content=<a href='/topic/show?id=3d0d134904c' target=_blank style='color:#2F92EE;'>#OSA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13490, encryptionId=3d0d134904c, topicName=OSA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=322359, createdName=bioon3, createdTime=Sun Apr 01 12:18:00 CST 2012, time=2012-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1460292, encodeId=c037146029232, content=<a href='/topic/show?id=de5015845be' target=_blank style='color:#2F92EE;'>#SAH#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15845, encryptionId=de5015845be, topicName=SAH)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9f06287396, createdName=zexyw03, createdTime=Sun Apr 01 12:18:00 CST 2012, time=2012-04-01, status=1, ipAttribution=)]
    2015-10-06 笑笑笑子昂

    谢谢分享。

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=37758, encodeId=08673e75876, content=谢谢分享。, beContent=null, objectType=article, channel=null, level=null, likeNumber=193, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200723/f987384a19f54db58fdf3fa313ecf7b2/2405b3e51f384f5d87b2b06c7a0dd7ad.jpg, createdBy=88ac1654221, createdName=笑笑笑子昂, createdTime=Tue Oct 06 20:00:00 CST 2015, time=2015-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1755539, encodeId=46fb1e55539e5, content=<a href='/topic/show?id=1978134916f' target=_blank style='color:#2F92EE;'>#OSAHS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13491, encryptionId=1978134916f, topicName=OSAHS)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8aef36947190, createdName=ylz8415, createdTime=Tue Nov 20 20:18:00 CST 2012, time=2012-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1837086, encodeId=7871183e08659, content=<a href='/topic/show?id=3f34e253206' target=_blank style='color:#2F92EE;'>#相关性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72532, encryptionId=3f34e253206, topicName=相关性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9de34, createdName=shenxlcyp, createdTime=Mon Dec 03 05:18:00 CST 2012, time=2012-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=4159, encodeId=82184159b7, content=keyi, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d64528733, createdName=yourlikes, createdTime=Tue Apr 03 12:14:00 CST 2012, time=2012-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1349724, encodeId=14261349e242f, content=<a href='/topic/show?id=3d0d134904c' target=_blank style='color:#2F92EE;'>#OSA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13490, encryptionId=3d0d134904c, topicName=OSA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=322359, createdName=bioon3, createdTime=Sun Apr 01 12:18:00 CST 2012, time=2012-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1460292, encodeId=c037146029232, content=<a href='/topic/show?id=de5015845be' target=_blank style='color:#2F92EE;'>#SAH#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15845, encryptionId=de5015845be, topicName=SAH)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9f06287396, createdName=zexyw03, createdTime=Sun Apr 01 12:18:00 CST 2012, time=2012-04-01, status=1, ipAttribution=)]
    2012-11-20 ylz8415
  3. [GetPortalCommentsPageByObjectIdResponse(id=37758, encodeId=08673e75876, content=谢谢分享。, beContent=null, objectType=article, channel=null, level=null, likeNumber=193, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200723/f987384a19f54db58fdf3fa313ecf7b2/2405b3e51f384f5d87b2b06c7a0dd7ad.jpg, createdBy=88ac1654221, createdName=笑笑笑子昂, createdTime=Tue Oct 06 20:00:00 CST 2015, time=2015-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1755539, encodeId=46fb1e55539e5, content=<a href='/topic/show?id=1978134916f' target=_blank style='color:#2F92EE;'>#OSAHS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13491, encryptionId=1978134916f, topicName=OSAHS)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8aef36947190, createdName=ylz8415, createdTime=Tue Nov 20 20:18:00 CST 2012, time=2012-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1837086, encodeId=7871183e08659, content=<a href='/topic/show?id=3f34e253206' target=_blank style='color:#2F92EE;'>#相关性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72532, encryptionId=3f34e253206, topicName=相关性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9de34, createdName=shenxlcyp, createdTime=Mon Dec 03 05:18:00 CST 2012, time=2012-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=4159, encodeId=82184159b7, content=keyi, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d64528733, createdName=yourlikes, createdTime=Tue Apr 03 12:14:00 CST 2012, time=2012-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1349724, encodeId=14261349e242f, content=<a href='/topic/show?id=3d0d134904c' target=_blank style='color:#2F92EE;'>#OSA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13490, encryptionId=3d0d134904c, topicName=OSA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=322359, createdName=bioon3, createdTime=Sun Apr 01 12:18:00 CST 2012, time=2012-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1460292, encodeId=c037146029232, content=<a href='/topic/show?id=de5015845be' target=_blank style='color:#2F92EE;'>#SAH#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15845, encryptionId=de5015845be, topicName=SAH)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9f06287396, createdName=zexyw03, createdTime=Sun Apr 01 12:18:00 CST 2012, time=2012-04-01, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=37758, encodeId=08673e75876, content=谢谢分享。, beContent=null, objectType=article, channel=null, level=null, likeNumber=193, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200723/f987384a19f54db58fdf3fa313ecf7b2/2405b3e51f384f5d87b2b06c7a0dd7ad.jpg, createdBy=88ac1654221, createdName=笑笑笑子昂, createdTime=Tue Oct 06 20:00:00 CST 2015, time=2015-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1755539, encodeId=46fb1e55539e5, content=<a href='/topic/show?id=1978134916f' target=_blank style='color:#2F92EE;'>#OSAHS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13491, encryptionId=1978134916f, topicName=OSAHS)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8aef36947190, createdName=ylz8415, createdTime=Tue Nov 20 20:18:00 CST 2012, time=2012-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1837086, encodeId=7871183e08659, content=<a href='/topic/show?id=3f34e253206' target=_blank style='color:#2F92EE;'>#相关性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72532, encryptionId=3f34e253206, topicName=相关性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9de34, createdName=shenxlcyp, createdTime=Mon Dec 03 05:18:00 CST 2012, time=2012-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=4159, encodeId=82184159b7, content=keyi, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d64528733, createdName=yourlikes, createdTime=Tue Apr 03 12:14:00 CST 2012, time=2012-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1349724, encodeId=14261349e242f, content=<a href='/topic/show?id=3d0d134904c' target=_blank style='color:#2F92EE;'>#OSA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13490, encryptionId=3d0d134904c, topicName=OSA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=322359, createdName=bioon3, createdTime=Sun Apr 01 12:18:00 CST 2012, time=2012-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1460292, encodeId=c037146029232, content=<a href='/topic/show?id=de5015845be' target=_blank style='color:#2F92EE;'>#SAH#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15845, encryptionId=de5015845be, topicName=SAH)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9f06287396, createdName=zexyw03, createdTime=Sun Apr 01 12:18:00 CST 2012, time=2012-04-01, status=1, ipAttribution=)]
    2012-04-03 yourlikes

    keyi

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=37758, encodeId=08673e75876, content=谢谢分享。, beContent=null, objectType=article, channel=null, level=null, likeNumber=193, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200723/f987384a19f54db58fdf3fa313ecf7b2/2405b3e51f384f5d87b2b06c7a0dd7ad.jpg, createdBy=88ac1654221, createdName=笑笑笑子昂, createdTime=Tue Oct 06 20:00:00 CST 2015, time=2015-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1755539, encodeId=46fb1e55539e5, content=<a href='/topic/show?id=1978134916f' target=_blank style='color:#2F92EE;'>#OSAHS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13491, encryptionId=1978134916f, topicName=OSAHS)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8aef36947190, createdName=ylz8415, createdTime=Tue Nov 20 20:18:00 CST 2012, time=2012-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1837086, encodeId=7871183e08659, content=<a href='/topic/show?id=3f34e253206' target=_blank style='color:#2F92EE;'>#相关性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72532, encryptionId=3f34e253206, topicName=相关性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9de34, createdName=shenxlcyp, createdTime=Mon Dec 03 05:18:00 CST 2012, time=2012-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=4159, encodeId=82184159b7, content=keyi, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d64528733, createdName=yourlikes, createdTime=Tue Apr 03 12:14:00 CST 2012, time=2012-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1349724, encodeId=14261349e242f, content=<a href='/topic/show?id=3d0d134904c' target=_blank style='color:#2F92EE;'>#OSA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13490, encryptionId=3d0d134904c, topicName=OSA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=322359, createdName=bioon3, createdTime=Sun Apr 01 12:18:00 CST 2012, time=2012-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1460292, encodeId=c037146029232, content=<a href='/topic/show?id=de5015845be' target=_blank style='color:#2F92EE;'>#SAH#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15845, encryptionId=de5015845be, topicName=SAH)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9f06287396, createdName=zexyw03, createdTime=Sun Apr 01 12:18:00 CST 2012, time=2012-04-01, status=1, ipAttribution=)]
    2012-04-01 bioon3
  6. [GetPortalCommentsPageByObjectIdResponse(id=37758, encodeId=08673e75876, content=谢谢分享。, beContent=null, objectType=article, channel=null, level=null, likeNumber=193, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200723/f987384a19f54db58fdf3fa313ecf7b2/2405b3e51f384f5d87b2b06c7a0dd7ad.jpg, createdBy=88ac1654221, createdName=笑笑笑子昂, createdTime=Tue Oct 06 20:00:00 CST 2015, time=2015-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1755539, encodeId=46fb1e55539e5, content=<a href='/topic/show?id=1978134916f' target=_blank style='color:#2F92EE;'>#OSAHS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13491, encryptionId=1978134916f, topicName=OSAHS)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8aef36947190, createdName=ylz8415, createdTime=Tue Nov 20 20:18:00 CST 2012, time=2012-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1837086, encodeId=7871183e08659, content=<a href='/topic/show?id=3f34e253206' target=_blank style='color:#2F92EE;'>#相关性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72532, encryptionId=3f34e253206, topicName=相关性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9de34, createdName=shenxlcyp, createdTime=Mon Dec 03 05:18:00 CST 2012, time=2012-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=4159, encodeId=82184159b7, content=keyi, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d64528733, createdName=yourlikes, createdTime=Tue Apr 03 12:14:00 CST 2012, time=2012-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1349724, encodeId=14261349e242f, content=<a href='/topic/show?id=3d0d134904c' target=_blank style='color:#2F92EE;'>#OSA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13490, encryptionId=3d0d134904c, topicName=OSA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=322359, createdName=bioon3, createdTime=Sun Apr 01 12:18:00 CST 2012, time=2012-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1460292, encodeId=c037146029232, content=<a href='/topic/show?id=de5015845be' target=_blank style='color:#2F92EE;'>#SAH#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15845, encryptionId=de5015845be, topicName=SAH)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9f06287396, createdName=zexyw03, createdTime=Sun Apr 01 12:18:00 CST 2012, time=2012-04-01, status=1, ipAttribution=)]
    2012-04-01 zexyw03